Completed
This public workshop provided a venue for stakeholders to (1) examine ways to advance regulatory science for MCM development and regulatory evaluation; (2) identify scientific opportunities to improve, simplify, or speed MCM development; and (3) identify tools and methods to improve the predictability and success rate of candidate MCMs.The workshop was co-hosted by the National Academies Forum on Drug Discovery, Development and Translation and the Forum on Medical and Public Health Preparedness for Disasters and Emergencies.
The workshop was held on March 29 - 30, 2011. Please visit our event page for additional information and meeting materials for the workshop.
Featured publication
Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary
Proceedings
·2011
Whether or not the United States has safe and effective medical countermeasures—such as vaccines, drugs, and diagnostic tools—available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at...
View details